SCOTTSDALE, Ariz. and DALLAS, Dec. 20, 2016 /PRNewswire/ — HonorHealth Research Institute and EndoStim, Inc., announced that the first two patients in Scottsdale, AZ have been implanted with the EndoStim device in the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim system is a minimally invasive implantable device designed to provide long-term reflux control by restoring normal function to the esophagus through neurostimulation.
http://www.prnewswire.com/news-releases/first-two-patients-at-honorhealth-research-institute-implanted-in-endostims-less-gerd-clinical-trial-for-gastroesophageal-reflux-disease-gerd-300381939.html
First two patients at HonorHealth Research Institute implanted in EndoStim’s LESS GERD clinical trial for gastroesophageal reflux disease (GERD)